KSE - Delayed Quote KRW

Celltrion, Inc. (068270.KS)

172,900.00 -4,200.00 (-2.37%)
At close: 3:30 PM GMT+9
Currency in KRW All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
2,176,431,531.38
2,176,431,531.38
2,283,967,480.39
1,893,401,217.21
1,849,115,532.11
Cost of Revenue
1,124,562,480.39
1,124,562,480.39
1,251,270,174.70
805,806,951.54
821,451,543.00
Gross Profit
1,051,869,050.99
1,051,869,050.99
1,032,697,305.69
1,087,594,265.67
1,027,663,989.11
Operating Expense
400,387,629.00
400,387,629.00
385,497,437.00
343,415,721.00
309,084,935.00
Operating Income
651,481,421.99
651,481,421.99
647,199,868.69
744,178,544.67
718,579,054.11
Net Non Operating Interest Income Expense
9,398,448.38
9,398,448.38
6,710,770.41
-3,834,921.09
-1,781,159.71
Pretax Income
671,095,784.99
671,095,784.99
626,173,376.62
738,623,430.51
657,152,016.00
Tax Provision
131,389,279.88
131,389,279.88
94,826,672.87
152,820,551.79
131,449,106.25
Net Income Common Stockholders
535,647,963.95
535,647,963.95
537,835,568.48
579,464,583.81
517,759,533.00
Basic EPS
3.76k
3.76k
3.74k
4.00k
3.58k
Diluted EPS
3.75k
3.75k
3.74k
3.98k
3.56k
Basic Average Shares
142,497.46
142,497.46
143,729.44
144,866.15
144,650.86
Diluted Average Shares
142,725.28
142,725.28
143,960.27
145,530.83
145,455.33
Total Operating Income as Reported
651,481,422.15
651,481,422.15
647,198,174.58
744,176,850.30
718,577,360.00
Rent Expense Supplemental
369,707.00
369,707.00
345,381.00
336,615.00
279,032.00
Total Expenses
1,524,950,109.39
1,524,950,109.39
1,636,767,611.70
1,149,222,672.54
1,130,536,478.00
Net Income from Continuing & Discontinued Operation
535,647,963.95
535,647,963.95
537,835,568.48
579,464,583.81
517,759,533.00
Normalized Income
529,204,230.72
529,204,230.72
537,729,094.89
589,370,155.00
519,362,131.18
Interest Income
19,063,734.00
19,063,734.00
14,218,305.00
4,396,155.00
5,722,184.00
Interest Expense
9,665,286.00
9,665,286.00
7,507,535.00
8,231,076.00
7,503,344.00
Net Interest Income
9,398,448.38
9,398,448.38
6,710,770.41
-3,834,921.09
-1,781,159.71
EBIT
680,761,070.99
680,761,070.99
633,680,911.62
746,854,506.51
664,655,360.00
EBITDA
926,588,402.99
926,588,402.99
860,070,934.62
961,014,241.51
838,505,160.00
Reconciled Cost of Revenue
1,124,562,480.39
1,124,562,480.39
1,251,270,174.70
805,806,951.54
821,451,543.00
Reconciled Depreciation
245,827,332.00
245,827,332.00
226,390,023.00
214,159,735.00
173,849,800.00
Net Income from Continuing Operation Net Minority Interest
535,647,963.95
535,647,963.95
526,616,038.97
569,488,023.72
517,759,533.00
Total Unusual Items Excluding Goodwill
8,012,433.00
8,012,433.00
-13,096,345.00
-25,068,856.00
-2,003,319.00
Total Unusual Items
8,012,433.00
8,012,433.00
-13,096,345.00
-25,068,856.00
-2,003,319.00
Normalized EBITDA
918,575,969.99
918,575,969.99
873,167,279.62
986,083,097.51
840,508,479.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
1,568,699.77
1,568,699.77
-1,983,289.08
-5,186,724.72
-400,720.82
12/31/2020 - 7/19/2005
Yahoo Finance Plus Essential access required. Unlock Access

Related Tickers

005690.KS Pharmicell Co., Ltd.
5,550.00
-2.97%
 
326030.KS SK Biopharmaceuticals Co., Ltd.
82,700.00
-2.01%
 
BION.SW BB Biotech AG
41.40
-0.84%
 
RLF.SW Relief Therapeutics Holding SA
1.3100
+3.97%
 
AVCT.L Avacta Group Plc
48.50
+1.04%
 
EDSA Edesa Biotech, Inc.
4.4500
+2.30%
 
VYNE VYNE Therapeutics Inc.
2.3125
+0.54%
 
CRVO CervoMed Inc.
24.15
-4.36%
 
ONT.L Oxford Nanopore Technologies plc
92.75
-1.85%
 
OLMA Olema Pharmaceuticals, Inc.
9.82
-0.81%